Chuck Carignan

Chuck Carignan is an accomplished executive in the medical device and biotechnology sectors, currently serving as the Executive Chair at CAIRDAC since July 2022. He is based in Paris, France, and has a robust background in product development and market access within the medical field.

Professional Experience

• Executive Chair, CAIRDAC (July 2022 - Present)
• Chief Experience Officer, SURGE Therapeutics (January 2022 - Present)
• Director, Biothea Pharma Inc. (July 2021 - Present)
• Executive Chair, SamanTree Medical SA (March 2020 - Present)
• CEO, SoniVie (March 2019 - December 2021): Led the development of innovative treatments for renal artery denervation and pulmonary hypertension.
• Director, Rex Bionics (April 2017 - June 2020): Focused on restructuring and repositioning the company’s product in the rehabilitation market.
• President and CEO, BionX Medical Technologies (June 2014 - March 2017): Oversaw the company until its acquisition by Ottobock.
• President and CEO, NinePoint Medical Inc. (January 2010 - June 2014)
• Executive Vice President, Novasys Medical (2005 - December 2009)
• Chief Medical Officer, Endosurgery at Boston Scientific Corporation (2002 - 2005)

Education

• Doctor of Medicine (MD) from Columbia University College of Physicians and Surgeons (1987 - 1991)
• Bachelor of Arts (BA) in American Studies from Yale University (1983 - 1987)

Skills and Languages

Carignan is fluent in French and Spanish, which complements his extensive international experience in the medical industry. His career reflects a strong commitment to advancing healthcare technology and improving patient outcomes through innovative solutions.1